title: Peritoneal dialysis catheter infections in children after renal transplantation: choosing the time of removal.
abstract: As a foreign body, the peritoneal dialysis (PD) catheter represents a potential source of infection, particularly for immunosuppressed renal transplant patients. A retrospective study was therefore undertaken to compare the risks and benefits of our policy of removing PD catheters at 3 months following renal transplant, which was established to allow for early re-initiation of dialysis. Between 1984 and 1990, 43 renal transplants were performed in 35 children who had been receiving maintenance PD. During the 1st month post transplantation, the PD catheter was used in 25 patients (58%) because of acute rejection or primary allograft non-function. Thirty-one patients were eventually discharged with functioning allografts and a PD catheter in place. Of them, 43% developed a catheter-related infection within the next 2 months, a period during which PD was not performed. Potential contributing factors included a history of catheter-related infection prior to transplantation, use of high-dose methylprednisolone to treat acute rejection, and the type of maintenance immunosuppression prescribed; conversely, the use of prophylactic antibiotics appeared to decrease this risk. This study established the potential need for the catheter during the first few weeks, but because of the infection risk of 43% by 3 months post transplantation, our protocol was revised to include catheter removal at the time of hospital discharge. From 1990 until the end of 1992, an additional 19 PD recipients underwent transplantation. In this group, catheters were used during the 1st month in 6 children (32%). Fifteen patients were discharged with a functioning allograft and only 1 patient returned to PD at 12 months post transplant. It is concluded that PD catheters represent an additional source of infection following transplantation and should be removed at the time of hospital discharge, after which the likelihood of use is low.
authors.affiliation: St. Christopher's Hospital for Children, Department of Nursing, Philadelphia, PA 19134-1095.
authors.forename: J A
authors.initials: JA
authors.lastname: Palmer
authors.forename: B A
authors.initials: BA
authors.lastname: Kaiser
authors.forename: M S
authors.initials: MS
authors.lastname: Polinsky
authors.forename: S P
authors.initials: SP
authors.lastname: Dunn
authors.forename: C
authors.initials: C
authors.lastname: Braas
authors.forename: R
authors.initials: R
authors.lastname: Waltz
authors.forename: H J
authors.initials: HJ
authors.lastname: Baluarte
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology; D001424:Bacterial Infections / Q000517:prevention & control*; D002408:Catheters, Indwelling / Q000382:microbiology*; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D010530:Peritoneal Dialysis / Q000295:instrumentation*; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents